Skip to Content
  • Previous Rank
    16
  • Revenues ($M)
    $192,487
  • Revenue Percent Change
    6.2%
  • Profits ($M)
    $2,258
  • Profits Percent Change
    53%
  • Assets ($M)
    $56,563
  • Employees
    68,000

McKesson, the largest U.S. pharmaceutical distributor, is facing some major headwinds these days. After years of strong sales growth thanks to generic drug price inflation, that tailwind is expected to slow and cut into the company’s overall revenue growth this year. McKesson also recently lost a handful of customers and could potentially lose another $13 billion worth of revenue in 2018 when (or if) Rite Aid is acquired by Walgreens. Management has been working on a series of maneuvers to lessen these blows, including acquiring strategic bolt-on companies to replace lost business and implementing a restructuring plan that’s expected to generate about $180 million in savings this fiscal year.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Information

CEO
John H. Hammergren
Sector
Wholesalers
Industry
Wholesalers: Health Care
HQ Location
San Francisco, CA
Employees68,000
Websitehttp://www.mckesson.com
Years on Global 500 List22
Figures are for fiscal year ended March 31, 2016.

McKesson Rank History

placeholder

Key Financials (last fiscal year)

($ Millions)% change
Revenues ($M)$192,4876.2%
Profits ($M)$2,25853%
Assets ($M)$56,563-
Total Stockholder Equity ($M)$8,924-

Profit Ratios

Profit as % of Revenues1.2%
Profits as % of Assets4%
Profits as % of Stockholder Equity25.3%